StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
24
This year
2
Publishing Date
2024 - 03 - 11
1
2024 - 01 - 23
1
2023 - 12 - 06
2
2023 - 11 - 27
1
2023 - 10 - 03
1
2023 - 08 - 07
1
2023 - 07 - 27
1
2023 - 04 - 17
1
2023 - 03 - 27
1
2023 - 02 - 27
1
2022 - 12 - 08
1
2022 - 11 - 08
1
2022 - 10 - 26
1
2022 - 07 - 21
1
2022 - 06 - 21
1
2022 - 04 - 28
1
2022 - 01 - 25
1
2021 - 10 - 26
1
2021 - 08 - 18
1
2021 - 05 - 26
1
2021 - 03 - 12
1
2020 - 12 - 21
1
2020 - 12 - 01
1
Sector
Health technology
24
Tags
Alliances
2
Application
2
Arm
1
Bioscience
20
Biotech
2
Biotech-bay
21
Biotech-beach
1
Biotechnology
10
Breast
10
Breast cancer
4
Business
3
Cancer
49
Car-t
22
Chinese
1
Clearance
2
Clinical-trials-phase-i
1
Conference
7
Congress
1
Covid
4
Covid-19
3
Events
9
Fda
4
Fda clearance
2
Global
2
Growth
1
Immunotherapy
2
International
1
Iot
1
Keytruda
1
License
1
Life science
1
Market
1
Medical
1
Meeting
4
Money
1
N/a
16
Offering
2
Ongoing
2
Ovarian cancer
15
Patent
13
People
3
Phase 1
1
Phase 2b
1
Positive
3
Pre-clinical
1
Preclinical
1
Presentation
8
Product-news
5
Publication
1
Report
1
Research
8
Sars-cov-2
1
Study
3
Symposium
3
Technology
10
Test
2
Therapy
16
Treatment
4
Trial
15
Vaccine
24
Entities
Anixa biosciences, inc.
24
Merck & company, inc.
1
Symbols
ABT
10
ACIU
10
AGEN
13
ALPMF
7
ALPMY
7
AMRS
8
ANIX
24
APDN
9
ARCT
18
ARVL
31
AZN
29
AZNCF
19
BNTX
111
BWV
20
CMXHF
7
CNC
8
CSLLY
7
CVAC
25
CVS
12
DVAX
82
DYAI
17
EBS
15
EVAX
17
FNCTF
34
GLAXF
35
GOVX
32
GRTS
23
GSK
56
IBRX
10
ICVX
7
INO
22
JNJ
327
LLY
8
MRK
20
MRNA
142
NRXP
11
NVAX
132
NVS
16
NVSEF
10
OCGN
25
ORMP
11
PAHC
9
PCVX
10
PDSB
9
PFE
106
SNGX
12
SNY
258
SNYNF
163
SRNE
8
STRO
9
TAK
27
TMO
8
TNXP
26
TSN
8
VAXX
9
VBIV
64
VCNX
34
VIR
9
VXRT
44
ZTS
9
Exchanges
Nasdaq
24
Nyse
1
Crawled Date
2024 - 03 - 11
1
2024 - 01 - 23
1
2023 - 12 - 06
2
2023 - 11 - 27
1
2023 - 10 - 03
1
2023 - 08 - 07
1
2023 - 07 - 27
1
2023 - 04 - 17
1
2023 - 03 - 27
1
2023 - 02 - 27
1
2022 - 12 - 08
1
2022 - 11 - 08
1
2022 - 10 - 26
1
2022 - 07 - 21
1
2022 - 06 - 21
1
2022 - 04 - 28
1
2022 - 01 - 25
1
2021 - 10 - 26
1
2021 - 08 - 18
1
2021 - 05 - 26
1
2021 - 03 - 12
1
2020 - 12 - 21
1
2020 - 12 - 01
1
Crawled Time
13:00
2
13:15
2
13:20
3
13:30
3
14:00
5
14:20
1
14:30
1
15:00
1
17:00
2
21:00
1
22:00
1
23:00
2
Source
www.biospace.com
21
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Vaccine
symbols :
Anix
save search
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-2.15%
|
O:
-1.23%
H:
2.18%
C:
0.62%
vaccine
congress
world
presentation
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Published:
2024-01-23
(Crawled : 13:30)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-34.43%
|
O:
0.0%
H:
3.09%
C:
1.03%
patent
vaccine
cancer
technology
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Published:
2023-12-06
(Crawled : 23:00)
- prnewswire.com
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-19.08%
|
O:
2.29%
H:
5.63%
C:
-10.45%
vaccine
breast
positive
cancer
study
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Published:
2023-12-06
(Crawled : 21:00)
- prnewswire.com
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-19.08%
|
O:
2.29%
H:
5.63%
C:
-10.45%
conference
vaccine
breast
positive
cancer
ongoing
study
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Published:
2023-11-27
(Crawled : 13:30)
- prnewswire.com
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
7.43%
|
O:
-0.34%
H:
8.47%
C:
5.08%
patent
vaccine
cancer
technology
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Published:
2023-10-03
(Crawled : 13:30)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
5.3%
|
O:
4.64%
H:
0.95%
C:
-3.48%
patent
vaccine
cancer
technology
Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial
Published:
2023-08-07
(Crawled : 14:00)
- biospace.com/
MRK
|
$127.0
0.1%
0.63%
5.7M
|
Health Technology
|
20.95%
|
O:
0.28%
H:
0.94%
C:
0.76%
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-15.2%
|
O:
0.0%
H:
2.66%
C:
-4.27%
keytruda
arm
vaccine
breast
cancer
ongoing
trial
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
Published:
2023-07-27
(Crawled : 13:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-10.42%
|
O:
2.25%
H:
2.2%
C:
-2.2%
patent
vaccine
cancer
technology
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Published:
2023-04-17
(Crawled : 23:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-46.73%
|
O:
1.84%
H:
6.09%
C:
-25.82%
vaccine
breast
positive
cancer
study
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting
Published:
2023-03-27
(Crawled : 14:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-27.06%
|
O:
-0.23%
H:
9.43%
C:
6.44%
vaccine
breast
presentation
cancer
meeting
trial
Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
Published:
2023-02-27
(Crawled : 14:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-18.46%
|
O:
-0.51%
H:
9.54%
C:
8.51%
patent
vaccine
breast
technology
cancer
Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
Published:
2022-12-08
(Crawled : 14:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-34.97%
|
O:
-0.2%
H:
1.84%
C:
-5.33%
vaccine
breast
trial
cancer
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Published:
2022-11-08
(Crawled : 14:20)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-40.23%
|
O:
-1.5%
H:
2.67%
C:
-1.15%
vaccine
breast
symposium
trial
presentation
cancer
Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
Published:
2022-10-26
(Crawled : 13:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-39.54%
|
O:
0.76%
H:
10.38%
C:
9.62%
vaccine
breast
trial
cancer
phase 2b
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
Published:
2022-07-21
(Crawled : 13:20)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-5.07%
|
O:
-1.49%
H:
12.12%
C:
10.0%
patent
vaccine
technology
cancer
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
Published:
2022-06-21
(Crawled : 13:20)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
2.25%
|
O:
2.25%
H:
0.0%
C:
0.0%
research
vaccine
technology
cancer
publication
ovarian cancer
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Published:
2022-04-28
(Crawled : 13:20)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
19.1%
|
O:
4.12%
H:
2.52%
C:
-2.16%
vaccine
trial
presentation
cancer
breast cancer
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
Published:
2022-01-25
(Crawled : 14:30)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
5.3%
|
O:
0.33%
H:
3.96%
C:
1.32%
patent
ovarian cancer
bioscience
cancer
vaccine
Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
Published:
2021-10-26
(Crawled : 14:00)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-25.35%
|
O:
2.58%
H:
0.0%
C:
0.0%
cancer
vaccine
breast cancer
Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology
Published:
2021-08-18
(Crawled : 13:15)
- biospace.com/
ANIX
|
$3.18
3.58%
0.97%
790
|
Health Technology
|
-21.29%
|
O:
3.47%
H:
7.18%
C:
5.26%
cancer
vaccine
patent
technology
ovarian cancer
bioscience
← Previous
1
2
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
BOF
|
$2.08
77.78%
39.06%
110M
|
BHIL
|
$0.1793
-4.37%
19.24%
340K
|
Agriculture, Forestry, Fishing ...
UMAC
|
$1.48
-1.33%
14.87%
20K
|
CI
|
$352.28
-0.11%
13.53%
2
|
Health Services
CIG.C
|
$2.89
-1.37%
12.8%
2.3K
|
n/a
MTH
|
$154.69
-2.21%
12.68%
450K
|
Consumer Durables
BMTX
4
|
$1.545
0.98%
10.03%
2.5K
|
Information
TAL
|
$12.26
0.57%
9.22%
12M
|
Consumer Services
ASXC
|
$0.243
-2.41%
7.0%
1.1M
|
Manufacturing
IHT
P
|
$1.3712
0.82%
6.48%
0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.